American Academy of Orthopaedic Surgeons issued the following announcement on Nov. 16.A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds arthroscopic (joint replacement or reconstruction) management could be a promising option for young, active patients diagnosed with GHOA.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it will assume full development and commercial responsibility for its collaboration with Galapagos (Euronext: GLPG) to discover and develop new therapies to treat cystic fibrosis (CF).

New Assays empower Clinicians to more quickly make the right diagnosis at the point-of-care and prescribe the right treatment

The American Brain Tumor Association (ABTA), the nation's first nonprofit organization dedicated to brain tumor education and research, is now accepting Letters of Intent (LOI) for three research funding opportunities.

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack.

Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance

AbbVie, a research-based global biopharmaceutical company, today announced a donation of $5 million to Family Reach to support the organization's efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States.

Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for heart disease later in life, according to new research in the American Heart Association’s journal Circulation.

Ensuring patients with heart failure have access to the latest evidence-based care, and improved outcomes and quality of life, is at the core of a hospital certification program offered by the American Heart Association, the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke, and The Joint Commission, the nation’s largest independent health care evaluation organization.

The AMA House of Delegates has adopted new policy opposing so-called lockout provisions that block Medicaid patients from the program for lengthy periods.

Takeda today announced its U.S. Business Unit will further expand its patient assistance program to help more patients access their medications.

Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis and Vascular Biology, an American Heart Association journal.

The Department of Justice (DOJ) announced last night it will not defend several critical patient protections in the health law and instead is arguing to end them.

The American Heart Association joins the nation in mourning the loss of former First Lady Barbara Bush. Mrs. Bush passed away this evening after reports that she had chosen comfort care over further medical treatment for her failing health.

For J.R. Bourne, a day at the beach rekindles good and bad memories.

The “informal” costs of caregiving for Americans with heart disease and stroke are projected to more than double by 2035, according to a new analysis.

The sun’s radiation could be a factor in seasonal patterns of a deadly type of heart attack, according to new research that tracked a “summer shift” in their occurrence across seven countries.

H. Lundbeck A/S, a Danish pharmaceutical firm focused on psychiatric and neurological treatments, recently announced its partnership with Vanderbilt University to license and advance collaborative research for treating schizophrenia cases.

Bullying, violence and other adversities witnessed or experienced by children and teens are likely to take a toll on their cardiovascular health, increasing chances of disease in adulthood, according to the American Heart Association (AHA).

Pharmacy benefit managers (PBMs), companies that act as middlemen in the prescription drug supply chain, posted revenues totaling more than $260 billion last year.